Latest News about Phase 2 Trial
Recent news which mentions Phase 2 Trial
Vertex Unveils First Patient Results On Potential Diabetes Treatment
October 18, 2021
Tickers
VRTX
From Benzinga
Denali Highlights Encouraging Early Data, Update For Amyotrophic Lateral Sclerosis Program
October 07, 2021
From Benzinga
Vaxart Starts Recruitment In Mid-Stage COVID-19 Oral Vaccine Trial
October 06, 2021
Tickers
VXRT
From Benzinga
Takeda Discontinues Two Mid-Stage Narcolepsy Trials
October 06, 2021
From Benzinga
Gemini Axes Chief Scientific Officer, 20% Of Staff To Focus On Geographic Atrophy Candidate
October 05, 2021
Tickers
GMTX
From Benzinga
EXCLUSIVE: Annovis Bio's Parkinson's Candidate Improves Speed, Motor Function Vs Placebo
October 05, 2021
Tickers
ANVS
From Benzinga
Enanta To Discontinue Internal Development Of NASH Candidates
October 04, 2021
Tickers
ENTA
From Benzinga
Xenon Pharma Shares Jump After Epilepsy Treatment Phase 2 Data Meets Primary Endpoint
October 04, 2021
Tickers
XENE
From Benzinga
J&J's RSV Vaccine Candidate Shows 80% Efficacy In Older Adults
October 04, 2021
Tickers
JNJ
From Benzinga
Eli Lilly's Mirikizumab Maintains Symptomatic Remission for Two Years In Ulcerative Colitis Patients
October 01, 2021
Tickers
LLY
From Benzinga
Precigen Posts Additional Interim Data From Type 1 Diabetes Trial
October 01, 2021
From Benzinga
From Benzinga
Minerva Posts Positive Bioequivalence Results For Schizophrenia Candidate Formulations
September 30, 2021
Tickers
NERV
From Benzinga
AIM ImmunoTech Recruits hVIVO For Ampligen Trial For Prophylaxis Use Against Respiratory Viruses
September 30, 2021
Tickers
AIM
From Benzinga
Regeneron-Roche Post Encouraging New Data For COVID-19 Antibody Cocktail
September 30, 2021
From Benzinga
Here's Why Editas Stock Dropped After Data From CRISPR-Based Retinal Disorder Candidate
September 29, 2021
Tickers
EDIT
From Benzinga
Adagio's COVID-19 Candidate Shows Prolonged Half-Life, Neutralization At Six Months
September 29, 2021
From Benzinga
Graybug Vision Posts Six-Month Extension GB-102 Data Of Wet AMD Trial
September 28, 2021
From Benzinga
Why Are I-Mab Shares Trading Higher On Tuesday?
September 28, 2021
From Benzinga
Valneva, Pfizer Lyme Disease Vaccine Candidate Drops-Off After 18 Months
September 28, 2021
From Benzinga
Ultragenyx Resumes Dosing Antisense Trial In Rare Neurogenetic Disorder
September 27, 2021
Tickers
RARE
From Benzinga
Pfizer Kick Starts Late-Stage Study For COVID-19 Oral Antiviral For Post-Exposure Prophylaxis
September 27, 2021
Tickers
PFE
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.